TG Therapeutics, Inc.
TGTX
$30.63
-$1.04-3.28%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -61.42% | 15.93% | 31.68% | 42.98% | 48.82% |
| Total Receivables | 129.32% | 176.91% | 192.57% | 152.84% | 194.32% |
| Inventory | 73.56% | 91.03% | 102.99% | 177.37% | 152.34% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 71.14% | 260.07% | 151.88% | 65.10% | 91.03% |
| Total Current Assets | 4.48% | 70.62% | 78.74% | 78.13% | 79.89% |
|
|
|||||
| Total Current Assets | 4.48% | 70.62% | 78.74% | 78.13% | 79.89% |
| Net Property, Plant & Equipment | -12.28% | -12.33% | -13.11% | -11.17% | -11.82% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10,753.65% | -3.02% | 26.18% | -6.18% | 23.96% |
| Total Assets | 74.91% | 75.12% | 75.90% | 75.28% | 77.01% |
|
|
|||||
| Total Accounts Payable | -19.96% | 20.38% | 29.84% | -10.16% | 128.91% |
| Total Accrued Expenses | 48.87% | 67.06% | 42.72% | 24.75% | 20.95% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 53.70% | 12.69% | 16.72% | 0.83% | -25.44% |
| Total Finance Division Other Current Liabilities | 112.74% | 153.38% | 167.93% | 352.36% | 161.89% |
| Total Other Current Liabilities | 112.74% | 153.38% | 167.93% | 352.36% | 161.89% |
| Total Current Liabilities | 25.33% | 58.18% | 60.72% | 68.80% | 116.92% |
|
|
|||||
| Total Current Liabilities | 25.33% | 58.18% | 60.72% | 68.80% | 116.92% |
| Long-Term Debt | 0.48% | 138.97% | 141.53% | 144.14% | 146.85% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -13.20% | -12.73% | -12.28% | -11.89% | -11.58% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -48.36% | -55.46% | 103.39% | 100.88% | 8,408.42% |
| Total Liabilities | 6.08% | 90.57% | 96.70% | 110.15% | 136.84% |
|
|
|||||
| Common Stock & APIC | 3.75% | 3.47% | 5.41% | 2.76% | 4.93% |
| Retained Earnings | 28.82% | 3.88% | 0.06% | 1.51% | -3.51% |
| Treasury Stock & Other | -4,106.21% | -9,298.29% | -6,360.26% | -3,743.59% | -918.38% |
| Total Common Equity | 216.00% | 55.68% | 48.20% | 38.54% | 16.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 216.00% | 55.68% | 48.20% | 38.54% | 16.62% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 216.00% | 55.68% | 48.20% | 38.54% | 16.62% |
|
|
|||||